Company: MBIO
Filing Date: 2025-12-03
Form Type: DEF 14A
Source: 0001104659-25-118122
Chunk: 57

Company: MUSTANG BIO, INC.
Filing Date: 2025-12-03
Form: DEF 14A
Chunk 57
---
 | Stock Units Granted |
| ​                                                                      | ​ |         Since Plan | ​ | under the EIP Since |
| ​                                                                      | ​ |          Inception | ​ |      Plan Inception |
| Name and Position                                                      | ​ |       -# of Shares | ​ |        -# of Shares |
| Manuel Litchman, M.D.                                                  |   |              1,388 |   |                 505 |
| President, Chief Executive Officer and Interim Chief Financial Officer |   |                    |   |                     |
| All Executive Officers as a Group                                      |   |              1,388 |   |                 505 |
| All Employees as a Group (excluding executive officers)                |   |                  — |   |               3,093 |
| All Non-Employees as a Group                                           |   |                133 |   |                 536 |
| All Non-Employee Directors as a Group                                  |   |                  — |   |               1,787 |

Securities Authorized for Issuance Under Equity Compensation Plans The following table contains information about our equity compensation plans as of December 31, 2024.

| ​                                                          
 ​                                                          
 ​                                                          
 ​                                                          
 ​                                                          
 ​                                                          
 ​                                                          
 ​                                                          
 ​                                                          
 Plan Category                                              
 ​                                                          | ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ |                                    ​ 
 Equity Compensation Plan Information 
                                    ​ 
                                    ​ 
                                    ​ 
                                    ​ 
           Number of securities to be 
              issued upon exercise of 
                 outstanding options, 
                  warrants and rights 
                                  (a) | ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ | ​                 
 ​                 
 ​                 
 Weighted-         
 average           
 exercise price of 
 outstanding       
 options, warrants 
 and rights        
 (b)               |        ​ 
        ​ 
        ​ | ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ |                     ​ 
                     ​ 
  Number of securities 
   remaining available 
   for future issuance 
          under equity 
    compensation plans 
 (excluding securities 
          reflected in 
           column (a)) 
                   (c) |
|:-----------------------------------------------------------|:--|-------------------------------------:|:--|:------------------|---------:|:--|----------------------:|
| Equity compensation plans approved by security holders     |   |                                1,521 | ​ | $                 |